To allow meaningful comparison of the pharmacological effects of different i.v. anaesthetics given by continuous infusion, it is necessary to define a measure of potency in a manner similar to that established for volatile anaesthetics. The minimum infusion rate (MIR) was introduced (Sear and Prys-Roberts, 1979) to define the ED 60 of an i.v. anaesthetic which suppressed movement in response to the surgical incision. Unlike its corollary, the minimum alveolar concentration (MAC) of an inhalation anaesthetic, MIR does not necessarily equate with the concentration of the anaesthetic in the blood. Both MAC and MIR should be determined under steady-state conditions of anaesthesia and only an approximation is made by determining the response, or lack of response, to the initial surgical incision when a state of stable anaesthesia, as opposed to a true pharmacological steady-state, has been established.
For patients premedicated with morphine sulphate and breathing 67% nitrous oxide in oxygen, the MIR of the Cremophor EL formulation of propofol was determined to be 51.3 ug kg" 1 min" 1 (Prys-Roberts, Sear and Adam, 1981) . Different induction pharmacodynamics have been reported (Cummings et al., 1984) for the newer emulsion formulation of propofol (1 % 2,6 di-isopropyl phenol in an emulsion of 10% soya bean oil, 2.25% glycerol and 1.2% egg phosphatide) as compared with the formulation in Cremophor EL. Therefore, as a prelude to pharmacological studies of continuous infusion anaesthesia, we have determined the ED M and ED 96 for propofol in patients premedicated with morphine sulphate and breathing nitrous oxide.
SUMMARY

PATIENTS AND METHODS
Each patient gave informed consent to participate in the study which had been approved by both the Committee on Safety of Medicines and the Hospital Ethical Committee. Healthy patients (ASA I or II) scheduled for body surface surgery were premedicated with morphine sulphate 0.15 mg kg" 1 i.m. lh before anaesthesia. The ±11.5 4/4 details of the first 40 patients are shown in table I (study A). Initially, five different rates of infusion were studied and eight patients randomly allocated to each group. We also include the response to surgical incision of 17 patients managed identically to those above, but participating in the subsequent pharmacokinetic studies: infusions of 54 or 108 (ig kg" 1 min" 1 were administered to nine and eight patients, respectively. Their details are shown in table I (study B). Under local analgesia, a 16-gauge cannula was placed in a forearm vein, a blood sample taken and the concentration of propofol measured (baseline). Propofol was administered from a calibrated syringe pump (Vickers Treonic: IP3) connected to this cannula; no other drugs were injected through this system.
Patients were asked to report any sensations associated with induction at the time. Anaesthesia was induced with propofol 2 mg kg" 1 given i.v. over 20 s. The propofol infusion of 40, 50, 54, 60, 70, 80 or 108 ug kg" 1 min" 1 was started immediately after induction. The infusion supplemented anaesthesia maintained with 67% nitrous oxide in oxygen inhaled from a face mask and Lack breathing system. An oral Guedel airway was used when appropriate. The surgical incision occurred at least 30 min after induction (median 35 min, range 30-105 min) and a sample of peripheral venous blood was obtained simultaneously from either an external jugular vein or a cubital vein in the arm contralateral to the infusion. The response to the incision was observed and the patients categorized as "movers" or "non-movers". Subsequently, anaesthesia was adjusted, as clinically appropriate, by incremental doses or an altered rate of infusion of propofol. One patient, who had received an infusion of 40 ug kg" 1 min" 1 before incision, required halothane during the subsequent anaesthetic maintenance. The arterial pressure (Dinamap 845, Critikon) and electrocardiogram were monitored in all patients throughout the study.
Nitrous oxide and the infusion of propofol (if still in progress) were discontinued simultaneously at the end of surgery. Oxygen-enriched air was administered by face mask until recovery was complete. The times from the discontinuation of anaesthesia to opening the eyes to command and to correct recall of birthdate were recorded. Patients were questioned 1 h after recovery from anaesthesia, and on the first day after operation, to assess recall of events before, during and after anaesthesia. The vein used for the administration of propofol was examined at these times. Whole blood propofol concentrations were determined by high pressure liquid chromatography with fluorescence detection at ICI Pharmaceuticals Division, Cheshire. Probit line analysis (Litchfield and Wilcoxon, 1949) was used to determine the ED 50 and ED B6 . Linear regression analysis was used to assess correlations between the whole blood concentration of propofol at incision and the rate of infusion, and the log-transformed recovery times and the total dose of propofol given. log-dose probit plot, the ED 60 was determined to be 53.5 ug kg" 1 min" 1 (95% confidence limits: 39.9-63.0 ug kg-1 min~l) and the ED 96 to be 112.2 ug kg" 1 min" 1 (85.6-306.2 ug kg" 1 min-1 ). Assays of baseline blood samples for propofol concentration were negative. There was a strong correlation (r* = 0.51, P < 0.001) between whole blood propofol concentration and the infusion rate at the time of incision ( fig. 2) . The mean whole blood propofol concentrations at the ED M and ED B6 infusion rates were 1.67 ug ml" 1 and 3.38 ug ml" 1 , respectively. Details of the duration of anaesthesia, surgery and recovery are given in table III. There was no correlation between the total dose of propofol given (mg kg" 1 ) and the times either to response to command, or to recall of birth date.
All patients were haemodynamically stable throughout anaesthesia and no significant arrhythmias occurred. No patient could recall any event during anaesthesia or surgery. There was no phlebitis or thrombosis of the vein used for the administration of the propofol in any patient within 24 h of the infusion.
DISCUSSION
The introduction of a new formulation for propofol as an aqueous emulsion raised numerous questions concerning dose requirement for induction and maintenance of anaesthesia. Cummings and colleagues (1984) found that the dose of propofol required to induce anaesthesia was about 25% greater than that for the Cremophor formulation, suggesting a formulation-dependent difference in the distribution of the drug.
In order to determine the dose requirement for continuous infusion anaesthesia, we have used the probit analysis approach (Litchfield and Wilcoxon, 1949) under exactly the same conditions as those in which the maintenance infusion rates of Althesin or methohexitone were determined (Sear et al., 1983) . In all these studies, the simple strategy of a single induction dose followed by a predetermined continuous infusion has been used. While this strategy has the disadvantage that blood concentrations of the appropriate drug decrease to below the desired concentration after the peak associated with the induction dose, our subsequent studies (Prys-Roberts, Cockshott and Douglas, unpublished observations), of which the data at 54 and 108 ug kg" 1 min" 1 form a part, have indicated that, at the time of surgical incision in those patients, the whole blood propofol concentrations were within 5 % of those subsequently achieved during further periods of anaesthesia up to 120 min.
The ED 60 for propofol determined in the present study (53.5 ug kg" 1 min" 1 ) was only marginally higher than that for the Cremophor EL formulation (Prys-Roberts, Sear and Adam, 1981) . However, the MIR in the previous study was not determined by the same method of probit analysis, but by a bracketing technique in which the infusion rate required just to suppress movement in response to surgery was averaged for nine patients. The ED 60 /ED 96 concept also allows comparison of different anaesthetics given by infusion under comparable conditions. Values for Althesin and methohexitone have been reported following premedication with either morphine or diazepam (Sear et al., 1983) , and the influence of age on these relationships has also been described (Sear, Prys-Roberts and Phillips, 1984) . The new formulation of propofol is marginally less potent than methohexitone at the ED 60 , but the slope of the dose-response curve for propofol is rather natter, and the 95 % confidence limits at the ED M rather wider. Nevertheless the data provide a satisfactory basis for further haemodynamic and pharmacokinetic studies of infusions of propofol Monk et al., 1986) , and target infusion rates and blood concentrations for studies of open-loop computer controlled infusions of propofol. We have not been able to determine a correlation with age in the present study because of the relatively small numbers involved, but hope to accumulate sufficient data in subsequent studies to allow a comparison with the data for Althesin or methohexitone (Sear, Prys-Roberts and Phillips, 1984) .
The times to response to command and to correct recall of birth date were comparable to values observed with a number of anaesthetics given for short surgical procedures (Craig, Cooper and Sear, 1982) , even though the duration of anaesthesia in the present study was of the order of 1-2.5 h. The lack of correlation between the total dose of propofol and the chosen indicators of recovery confirms the findings of Kay and co-workers (1985) , who also found recovery to be considerably faster when the emulsion formulation of propofol was used to supplement nitrous oxide, compared with patients who received Althesin. Many of our patients, particularly those who had undergone general anaesthesia in the past, remarked on the "clear headedness" of their recovery. The general impression of rapid recovery was reinforced by the opinions of the recovery room staff.
The emulsion formulation of propofol provides a valuable addition to the small number of drugs currently available for infusion anaesthesia. Its clinical effects are predictable, consistent and associated with a rapid recovery.
